Lv3
390 积分 2023-09-05 加入
Tocilizumab is a promising treatment option for therapy resistant juvenile localized scleroderma patients
3天前
已完结
Juvenile Scleroderma
15天前
已完结
Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease
27天前
已完结
Telitacicept: First Approval
27天前
已完结
Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases
27天前
已完结
Systemic therapy in juvenile localized scleroderma
1个月前
已完结
Symptomatic polyautoimmunity at diagnosis of 1463 childhood-onset lupus: A Brazilian multicenter study
5个月前
已完结
Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective study
5个月前
已完结
Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients
5个月前
已完结
Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis
5个月前
已完结
皖公网安备34019202002308
